Annovis Bio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,734 | -4,387 | -7,762 | -7,809 |
EBIT | -7,762 | -7,809 | ||
Net Income | -5,864 | -12,638,357 | -5,020 | -1,066 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,285 | -3,201 | -3,375 | -7,032 |
Cash | 10,551 | 12,636 | 3,997 | 3,136 |
Basic Shares | 13,794 | 12,975 | 11,307 | 10,625 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -45,035 | -25,511 | -14,500 | |
EBIT | -45,035 | -25,511 | -29,037 | |
Net Income | -24,590,375 | -56,204 | -25,145 | -14,437 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 37,611 | |||
Free Cash Flow | -21,894,604 | -39,967 | -17,312 | -9,132 |
Cash | 10,551 | 5,754 | 28,377 | 45,686 |
Basic Shares | 12,235 | 9,023 | 8,162 | 7,626 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.43 |
2024-09-30 | -$0.97 |
2024-06-30 | -$0.32 |
2024-03-31 | -$0.72 |
